Delivery Order SPE2DR25D2003-SPE2DR26FQ95A
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,487.82 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order represents a non-set-aside award issued under competitive procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $8,523.37 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on November 3, 2025, with a completion date of November 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a direct pharmaceutical procurement supporting federal healthcare requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $2,624.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitive award, which carries no set-aside designation, represents a pharmaceutical supply delivery to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg with a ceiling value of $20,863.60. This competitive, firm fixed-price delivery order was issued on April 25, 2025, with an ultimate completion date of April 28, 2025. The award is performance-based in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a...
- The Defense Logistics Agency awarded a $3,081.81 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Multaq 400 mg tablets (60-count). This firm fixed price contract, with an ultimate completion date of November 5, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,110.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on June 25, 2025, with completion expected by June 26, 2025. This competitively awarded contract, issued without set-aside designation, represents a firm fixed price delivery order for pharmaceutical supply to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $5,713.28 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This competitive award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $6,351.04 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under...
- The Defense Logistics Agency awarded a $3,056.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. The order was competitively awarded without a set-aside designation and is scheduled for completion by November 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and military healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $3,200.00 for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, with performance completed by August 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FQ95ADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,035.43 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on November 6, 2025, with completion scheduled for November 7, 2025. This competitively awarded, firm fixed-price delivery order reflects the agency's ongoing pharmaceutical procurement needs. The award was issued under a non-set-aside basis, indicating open competition among qualified vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract vehicle encompasses specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 11/6/25 |